Recent machine-extracted executive movements from SEC 8-K Item 5.02 filings, source-linked. Every card cites the SEC source.
Showing 401–450 of 34661
the remaining members of the Company’s Board of Directors (the “Board”) appointed Mika Grasso, Katharyn Field and Jatinder Dhaliwal (collectively, the “New Directors”), designees of the Lender, as directors of the Company.
Effective June 11, 2026, pursuant to the Revolving Loan Agreement, Francisco Silva, Nickolay Kukekov and Patrick F. Williams resigned as directors of the Company.
Effective June 11, 2026, pursuant to the Revolving Loan Agreement, Francisco Silva, Nickolay Kukekov and Patrick F. Williams resigned as directors of the Company.
Effective June 11, 2026, pursuant to the Revolving Loan Agreement, Francisco Silva, Nickolay Kukekov and Patrick F. Williams resigned as directors of the Company.
the remaining members of the Company’s Board of Directors (the “Board”) appointed Mika Grasso, Katharyn Field and Jatinder Dhaliwal (collectively, the “New Directors”), designees of the Lender, as directors of the Company.
the remaining members of the Company’s Board of Directors (the “Board”) appointed Mika Grasso, Katharyn Field and Jatinder Dhaliwal (collectively, the “New Directors”), designees of the Lender, as directors of the Company.
On June 8, 2026, in connection with the IPO, Marco Carrai, Paul Chellgren and George Muñoz (collectively with Ian Snow and Nathaniel Rothschild, the “Directors”) were appointed to the board of directors of the Company (the “Board”).
On June 8, 2026, in connection with the IPO, Marco Carrai, Paul Chellgren and George Muñoz (collectively with Ian Snow and Nathaniel Rothschild, the “Directors”) were appointed to the board of directors of the Company (the “Board”).
On June 8, 2026, in connection with the IPO, Marco Carrai, Paul Chellgren and George Muñoz (collectively with Ian Snow and Nathaniel Rothschild, the “Directors”) were appointed to the board of directors of the Company (the “Board”).
On June 9, 2026, Matthew Faber informed Tri-County Financial Group, Inc. (the “Company”) of his intent to resign from the Company’s Board of Directors (the “Board”), which became effective June 11, 2026.
appointed Christiane Pendarvis to fill the vacancy so created, effective as of July 2, 2026
On June 9, 2026, the Board appointed Barron Steele to serve as a Class II director, effective as of the Effective Date
On June 9, 2026, Andrew Broderick announced his intention to resign from the Board of Directors (the “Board”) of Frontier Group Holdings, Inc. (the “Company”), effective June 15, 2026
On June 12, 2026, Tim Walbert, a member of the Board of Directors (the “Board”) of Sagimet Biosciences Inc. (the “Company”), tendered his resignation from the Board, effective as of June 12, 2026.
On June 11, 2026, the Board of Directors (the “ Board ”) of Atara Biotherapeutics, Inc. (the “ Company ”) appointed Brian Cherry to serve as a member of the Board as a Class I director, effective June 11, 2026 (the “ Effective Date ”).
On June 12, 2026, the Board of Directors (the 'Board') of Fastenal Company (the 'Company') elected as a director of the Company Mr. Vishal Talwar, effective on June 12, 2026
appointed Dr. Nigam H. Shah to the Board as a Class III director to fill the resulting vacancy.
On June 11, 2026, the Board of Directors of Medallion Bank appointed Donald Poulton to serve as a member of its Board of Directors, effective July 1, 2026.
the Board of Directors (the “Board”) of OPENLANE, Inc. (the “Company”) increased the size of the Board to ten (10) directors and elected David Hult as a director of the Company, effective June 12, 2026.
On June 11, 2026, Michael Amoroso resigned as a member of the Board of Directors (the “Board”) of Abeona Therapeutics Inc. (the “Company”) effective immediately.
On June 10, 2026 (the “Effective Date”), the Board of Directors (the “Board”) of Palisade Bio, Inc. (the “Company”) expanded the size of the Board from five to six directors and appointed Jordan Zwick to the Board.
On June 5, 2026, Daniel M. McCabe notified Greenland Energy Company, a Texas corporation (the “Company”), of his resignation from his position as a member of the Board of Directors (the “Board”) of the Company, effective immediately.
On June 5, 2026, the Board appointed Carol Craig as a member of the Board, effective immediately, to serve as a Class I director filling the vacancy created by the resignation of Daniel M. McCabe.
and Alarcon Martinez Marcelo Ramon and Anna Toczko each resigned as a member of the Board, each effective as of June 5, 2026.
The Board also appointed Mr. Zokirov, as Chairman of the Board, Bahtiyor Kadirov, as an independent director on the Board, and Elina Davidyan, as an independent director on the Board to fill the vacancies created by the foregoing resignations.
The Board also appointed Mr. Zokirov, as Chairman of the Board, Bahtiyor Kadirov, as an independent director on the Board, and Elina Davidyan, as an independent director on the Board to fill the vacancies created by the foregoing resignations.
and Alarcon Martinez Marcelo Ramon and Anna Toczko each resigned as a member of the Board, each effective as of June 5, 2026.
On June 9 2026, Irwin Katsof notified IDT Corporation (the “Company”) of his resignation from the board of directors of the Company (the “Board”) and the respective committees of the Board on which he served.
On June 9, 2026, the Board appointed William Conkling to the Board.
The Board of Directors of Farmers & Merchants Bancorp (the “Company”) appointed Jehna Silva to serve as a director of the Company effective June 8, 2026.
each of Brian J. G. Pereira, MD, Benjamin L. Palleiko, William Fairey, Laurence Reid, PhD, Bethany Sensenig, Nancy Stuart, Patrick Treanor and Edward W. Unkart resigned from his or her respective positions as a member of the Company’s board of directors
each of Brian J. G. Pereira, MD, Benjamin L. Palleiko, William Fairey, Laurence Reid, PhD, Bethany Sensenig, Nancy Stuart, Patrick Treanor and Edward W. Unkart resigned from his or her respective positions as a member of the Company’s board of directors
each of Brian J. G. Pereira, MD, Benjamin L. Palleiko, William Fairey, Laurence Reid, PhD, Bethany Sensenig, Nancy Stuart, Patrick Treanor and Edward W. Unkart resigned from his or her respective positions as a member of the Company’s board of directors
John Hess, the sole director of Purchaser immediately prior to the Effective Time, became the sole director of the Company
each of Brian J. G. Pereira, MD, Benjamin L. Palleiko, William Fairey, Laurence Reid, PhD, Bethany Sensenig, Nancy Stuart, Patrick Treanor and Edward W. Unkart resigned from his or her respective positions as a member of the Company’s board of directors
each of Brian J. G. Pereira, MD, Benjamin L. Palleiko, William Fairey, Laurence Reid, PhD, Bethany Sensenig, Nancy Stuart, Patrick Treanor and Edward W. Unkart resigned from his or her respective positions as a member of the Company’s board of directors
each of Brian J. G. Pereira, MD, Benjamin L. Palleiko, William Fairey, Laurence Reid, PhD, Bethany Sensenig, Nancy Stuart, Patrick Treanor and Edward W. Unkart resigned from his or her respective positions as a member of the Company’s board of directors
each of Brian J. G. Pereira, MD, Benjamin L. Palleiko, William Fairey, Laurence Reid, PhD, Bethany Sensenig, Nancy Stuart, Patrick Treanor and Edward W. Unkart resigned from his or her respective positions as a member of the Company’s board of directors
each of Brian J. G. Pereira, MD, Benjamin L. Palleiko, William Fairey, Laurence Reid, PhD, Bethany Sensenig, Nancy Stuart, Patrick Treanor and Edward W. Unkart resigned from his or her respective positions as a member of the Company’s board of directors
On June 5, 2026, the Board of Directors (the “Board”) of PennyMac Financial Services, Inc. (the “Company”) elected Tiffany To as a member of the Board.
On June 10, 2026, Daniel Durn, a member of our board of directors (the "Board") and Chair of the Audit Committee, resigned from the Board, including from all committees of the Board on which he served, effective immediately, and was subsequently appointed by the Board to serve as the Company’s Chief Financial Officer and Executive Vice President and principal financial officer, effective June 15, 2026.
On June 9, 2026, in connection with the IPO, Keith Wyness and Robert Warfield were appointed to the board of directors of the Company
On June 9, 2026, in connection with the IPO, Keith Wyness and Robert Warfield were appointed to the board of directors of the Company
Mr. Grinberg, Mr. Wyness and Mr. Warfield are independent directors.
the Board of Directors of the Company (the “Board”) approved the appointment of Paul F. De Cock as Chief Executive Officer of the Company and as a Director on the Company’s Board, effective September 30, 2026
Tatiana Segal notified the Delegated Sponsor of her intention to resign from her position as a director of the Delegated Sponsor effective May 7, 2026.
Ruairi O’Healai notified Morgan Stanley Investment Management Inc., the delegated sponsor of Morgan Stanley Bitcoin Trust (the “Delegated Sponsor”), of his intention to resign from his position as a director of the Delegated Sponsor effective June 5, 2026.
the Company’s Board elected Kenneth Escoe to serve as a director of the Company, with a term beginning effective July 1, 2026.
Mr. Michael Goller, Mr. Ranjeev Krishana, Dr. Corazon (Corsee) D. Sanders and Mr. Qingqing Yi, whose terms expired at the Annual Meeting, did not stand for re-election at the Annual Meeting.
Mr. Michael Goller, Mr. Ranjeev Krishana, Dr. Corazon (Corsee) D. Sanders and Mr. Qingqing Yi, whose terms expired at the Annual Meeting, did not stand for re-election at the Annual Meeting.
Recent executive movements from 8-K Item 5.02 filings, source-linked. Cards are extracted by an LLM and gated to those whose source quote is present verbatim in the filing text. Coverage is best-effort while backfill and monitoring mature; this is not yet a full-market index. See methodology.